Related by context. Frequent words. (Click for all words.) 71 oncolytic virus therapies 70 Oncotype DX colon cancer 69 Completes Patient Enrollment 69 mSEPT9 69 NMP# 69 trastuzumab DM1 T DM1 69 refractory chronic lymphocytic 69 NMP# R 68 PreGen Plus 68 RPC Onko Sure 68 MammaPrint R 68 lung pancreatic 67 molecular diagnostic assays 67 www.vivus.com 67 Onko Sure ® 67 FOLOTYN ® 66 regarding Aethlon Medical 66 Initiates Phase II 66 breast pancreatic 66 BrachySil TM 66 colorectal lung 66 Septin 9 66 cervical breast 65 Corus CAD 65 ovarian breast 65 metastatic HER2 negative 65 metastatic colorectal 65 Maven Semantic 65 Receives Orphan Drug Designation 65 Natural Catastrophe Stress 65 BladderChek R 64 CLIA laboratory 64 Temsirolimus 64 Thiarabine 64 DNA Methylation 64 Hepatitis C HCV 64 drug Treanda 64 skin sterol 64 MassARRAY R 64 interstitial cystitis IC 64 Vitro Diagnostic 64 GVAX R 64 optical biosensors 64 Drug Shows Promise 64 Announces FDA Clearance 64 ThermoDox R 64 BCIRG 64 Nasdaq RGDX 64 sorafenib tablets 64 PSMA ADC 64 VEGFR2 inhibitor 63 NMP# BladderChek Test 63 Completes Enrollment 63 invasive lobular carcinoma 63 metastatic liver 63 metastatic carcinoma 63 www.QuestDiagnostics.com 63 Microvolt T Wave Alternans 63 Commences Phase 63 AviaraDx 63 ® bortezomib 63 FAMILION 63 Breast Cancer Recurrence 63 Phase Ib II 63 BrachySil 63 Genasense ® oblimersen 63 Accessed #/#/# [001] 63 www.qiagen.com 63 Prostate specific antigen 63 Phase IIb clinical trials 63 Allovectin 7 63 Lymphoseek ® 63 FDA Clears 63 www.adeonapharma.com 63 Presents Positive 62 BiTE R 62 Shows Promising 62 maternal serum 62 Protein Expression 62 Affymetrix GeneChip ® 62 www.delcath.com 62 Epidermal Growth Factor Receptor 62 NicAlert TM 62 R sorafenib tablets 62 Panzem R NCD 62 Vascugel ® 62 PNP inhibitor 62 Endometrial Cancer 62 radiotherapeutic 62 Pivotal Phase III 62 Diagnostic Tests 62 xMAP 62 thetreatment 62 www.allos.com 62 histone deacetylase HDAC inhibitor 62 DNA methyltransferase inhibitors 62 recombinant biopharmaceutical 62 http:/www.optimerpharma.com 62 targeted immunotherapies 62 Panzem R 62 Phase Ib IIa